Verification evidence is still being completed.
PDF / print export
MinervaX
Frederiksberg, Denmark
- Verified lead
- Per Fischer
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Vaccines, Maternal Immunization, Group B Streptococcus, Clinical Development, and Biotech
- Review cycle
- May 2026
- Full address
- Fasanvej 215, 2000 Frederiksberg, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official MinervaX document confirming the Frederiksberg in Copenhagen address.
- Editorial note
- MinervaX is published because official company materials confirm current leadership, Copenhagen-area operating address, and a real vaccine-development platform.
Vaccines, Maternal Immunization, Group B Streptococcus, Clinical Development, and Biotech
Official leadership disclosure, Official Copenhagen-area address disclosure, Vaccine platform claim
MinervaX is published because official company materials confirm current leadership, Copenhagen-area operating address, and a real vaccine-development platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Frederiksberg, Denmark
MinervaX
Vaccines, Maternal Immunization, Group B Streptococcus, Clinical Development, and Biotech · Clinical-stage vaccine platform
MinervaX runs vaccine development, maternal immunization programs, and clinical program execution in Frederiksberg, Denmark.
- Lead
- Per Fischer (verified ↗)
- Address
- Fasanvej 215, 2000 Frederiksberg, Denmark (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Clinical-stage vaccine platform
- Capabilities
- Vaccine Development · Maternal Immunization Programs · Clinical Program Execution
- Founded
- 2010
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Per Fischer
CEO
Full addressFasanvej 215, 2000 Frederiksberg, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official MinervaX job-ad document listing the Frederiksberg in Copenhagen address.
Open sourceClinical-stage vaccine platform
Frederiksberg, Denmark. Vaccines, Maternal Immunization, Group B Streptococcus, Clinical Development, and Biotech. Review completed on 22 Mar 2026.
Danish corporate and vaccine-development oversight
Official leadership disclosure, Official Copenhagen-area address disclosure, Vaccine platform claim
Vaccines, Maternal Immunization, Group B Streptococcus, Clinical Development, and Biotech
MinervaX is published because official company materials confirm current leadership, Copenhagen-area operating address, and a real vaccine-development platform.
Editorial note
MinervaX is published because official company materials confirm current leadership, Copenhagen-area operating address, and a real vaccine-development platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Vaccine Development
Maternal Immunization Programs
Clinical Program Execution
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Vaccine-development workflow
Clinical program systems
Platform management infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is MinervaX located?
- MinervaX operates from Fasanvej 215, 2000 Frederiksberg, Denmark, Frederiksberg, Denmark.
- Who runs MinervaX?
- MinervaX is led by Per Fischer, CEO. Verified 22 Mar 2026.
- What does MinervaX do?
- MinervaX runs vaccine development, maternal immunization programs, and clinical program execution in Frederiksberg, Denmark. Core capabilities: Vaccine Development, Maternal Immunization Programs, Clinical Program Execution.
Editorial context
Related technical briefs
Briefs that name Frederiksberg as a covered market or city.